Carnegie Mellon University researchers have created microscale living robots, termed AggreBots, engineered from human lung cells. These custom biobots represent a novel convergence of tissue engineering and robotics and hold future potential for targeted therapeutic delivery within complex biological environments. The research published in Science Advances demonstrates customizable motility and structural control in these synthetic biological entities.